These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Effects of minoxidil on hemodynamics in patients with congestive heart failure. Franciosa JA; Cohn JN Circulation; 1981 Mar; 63(3):652-7. PubMed ID: 7006852 [TBL] [Abstract][Full Text] [Related]
43. 5-HT2-receptor blockade in the treatment of heart failure. A preliminary study. Demoulin JC; Bertholet M; Soumagne D; David JL; Kulbertus HE Lancet; 1981 May; 1(8231):1186-8. PubMed ID: 6112531 [TBL] [Abstract][Full Text] [Related]
44. Hemodynamic assessment of oral peripheral vasodilator therapy in chronic congestive heart failure: prolonged effectiveness of isosorbide dinitrate. Williams DO; Bommer WJ; Miller RR; Amsterdam EA; Mason DT Am J Cardiol; 1977 Jan; 39(1):84-90. PubMed ID: 318795 [TBL] [Abstract][Full Text] [Related]
45. Effect of prostacyclin and prazosin in the treatment of congestive heart failure; with special reference to the sympathetic nervous system. Yui Y; Sakurai T; Nakajima H; Kawai C Jpn Circ J; 1984 Apr; 48(4):365-72. PubMed ID: 6371282 [TBL] [Abstract][Full Text] [Related]
46. Hemodynamic comparison of intravenous amrinone and dobutamine in patients with chronic congestive heart failure. Klein NA; Siskind SJ; Frishman WH; Sonnenblick EH; LeJemtel TH Am J Cardiol; 1981 Jul; 48(1):170-5. PubMed ID: 7246440 [TBL] [Abstract][Full Text] [Related]
47. Short-term intravenous sodium nitrite infusion improves cardiac and pulmonary hemodynamics in heart failure patients. Ormerod JO; Arif S; Mukadam M; Evans JD; Beadle R; Fernandez BO; Bonser RS; Feelisch M; Madhani M; Frenneaux MP Circ Heart Fail; 2015 May; 8(3):565-71. PubMed ID: 25838311 [TBL] [Abstract][Full Text] [Related]
48. Acute hemodynamic effects of bunazosin in congestive heart failure--differing responses according to degree of cardiac dysfunction. Ogino K; Noguchi N; Osaki S; Kitamura H; Matsumoto T; Kato M; Kinugawa T; Miyakoda H; Kotake H; Mashiba H Gen Pharmacol; 1993 Jul; 24(4):899-904. PubMed ID: 7901114 [TBL] [Abstract][Full Text] [Related]
50. Comparative hemodynamic effects of intravenous dobutamine and dibutyryl cyclic AMP, a new inotropic agent, in severe congestive heart failure. Miyagi Y; Sasayama S; Nakajima H; Fujita M; Asanoi H J Cardiovasc Pharmacol; 1990 Jan; 15(1):138-43. PubMed ID: 1688971 [TBL] [Abstract][Full Text] [Related]
51. The effect of flosequinan in patients with acute-onset heart failure complicating acute myocardial infarction. Schneeweiss A; Wynne RD; Marmor A Jpn Heart J; 1989 Sep; 30(5):627-34. PubMed ID: 2614925 [TBL] [Abstract][Full Text] [Related]
52. Sublingual nifedipine: acute effects in severe chronic congestive heart failure secondary to idiopathic dilated cardiomyopathy. Miller AB; Conetta DA; Bass TA Am J Cardiol; 1985 May; 55(11):1359-62. PubMed ID: 3993570 [TBL] [Abstract][Full Text] [Related]
53. Indoramin in heart failure: possible adverse effects on hemodynamics and exercise capacity. Seth L; Galiè N; Casebolt P; Gimenez H; Malloy M; Franciosa JA Clin Pharmacol Ther; 1986 Nov; 40(5):567-74. PubMed ID: 3769387 [TBL] [Abstract][Full Text] [Related]
54. Relative contribution of inotropic and vasodilator effects to amrinone-induced hemodynamic improvement in congestive heart failure. Konstam MA; Cohen SR; Weiland DS; Martin TT; Das D; Isner JM; Salem DN Am J Cardiol; 1986 Feb; 57(4):242-8. PubMed ID: 3004184 [TBL] [Abstract][Full Text] [Related]
55. Beneficial hemodynamic effects of intravenous terbutaline in patients with severe heart failure. Wang RY; Tse TF; Yu DY; Lee PK; Sum MS; Chow MS Am Heart J; 1982 Nov; 104(5 Pt 1):1016-21. PubMed ID: 7136991 [TBL] [Abstract][Full Text] [Related]
56. Development of pharmacodynamic tolerance to prozosin in congestive heart failure. Desch CE; Magorien RD; Triffon DW; Blanford MF; Unverferth DV; Leier CV Am J Cardiol; 1979 Nov; 44(6):1178-82. PubMed ID: 495512 [TBL] [Abstract][Full Text] [Related]
57. Acute hemodynamic effect of a vascular antagonist of vasopressin in patients with congestive heart failure. Nicod P; Waeber B; Bussien JP; Goy JJ; Turini G; Nussberger J; Hofbauer KG; Brunner HR Am J Cardiol; 1985 Apr; 55(8):1043-7. PubMed ID: 3885704 [TBL] [Abstract][Full Text] [Related]
58. Clinical use of sodium nitroprusside in chronic ischemic heart disease. Effects on peripheral vascular resistance and venous tone and on ventricular volume, pump and mechanical performance. Miller RR; Vismara LA; Zelis R; Amsterdam EA; Mason DT Circulation; 1975 Feb; 51(2):328-36. PubMed ID: 1112013 [TBL] [Abstract][Full Text] [Related]
59. The central haemodynamic effects of a single intravenous dose of flosequinan in patients with severe heart failure. Markus H; Cowley AJ Eur J Clin Pharmacol; 1991; 40(6):535-8. PubMed ID: 1884731 [TBL] [Abstract][Full Text] [Related]
60. Nonemergency use of slow infusions of diazoxide. Lee WR; Mroczek WJ; Davidov ME; Finnerty FS Clin Pharmacol Ther; 1975 Aug; 18(2):154-7. PubMed ID: 1097151 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]